137 related articles for article (PubMed ID: 3860295)
1. Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial.
Bertrand M; Multhauf P; Bartolucci A; Ellison D; Gockerman J
Cancer Treat Rep; 1985 Jun; 69(6):725-6. PubMed ID: 3860295
[No Abstract] [Full Text] [Related]
2. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
Chan C; Bartolucci A; Brenner D; Presant C; Davila E; Carpenter J; Greco FA; Clamon G; Moore J
Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Raney M; Logan T
Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
[No Abstract] [Full Text] [Related]
5. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Gockerman JP; Silberman H; Bartolucci AA
Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
[No Abstract] [Full Text] [Related]
6. Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Jun; 10(3):237-9. PubMed ID: 3473924
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
[No Abstract] [Full Text] [Related]
8. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
[TBL] [Abstract][Full Text] [Related]
10. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
Kish JA; Al-Sarraf M
Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
Thigpen JT; Samson MK
Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
[No Abstract] [Full Text] [Related]
12. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
13. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical study of carminomycin: its activity against soft tissue sarcomas.
Perevodchikova NI; Lichinitser MR; Gorbunova VA
Cancer Treat Rep; 1977 Dec; 61(9):1705-7. PubMed ID: 340034
[No Abstract] [Full Text] [Related]
15. Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.
Forastiere AA; Budman DR; Richards F; Aisner J; Weinberg V; Wood WC
Cancer Treat Rep; 1983 Dec; 67(12):1137-8. PubMed ID: 6580949
[No Abstract] [Full Text] [Related]
16. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Zidar BL; Baker LH; Rivkin SE; Balcerzak SP; Stephens RL
Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
[No Abstract] [Full Text] [Related]
17. Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.
Buesa JM; Mouridsen HT; Santoro A; Somers R; Bramwell V; van Oosterom AT; Wagener T; Vendrik C; Thomas D
Cancer Treat Rep; 1984 Apr; 68(4):683-4. PubMed ID: 6713423
[No Abstract] [Full Text] [Related]
18. [Therapeutic use of carminomycin in soft tissue sarcomas].
Perevodchikova NI; Gorbunova VA; Lichinitser MR; Moroz LV
Antibiotiki; 1976 Jul; 21(7):657-60. PubMed ID: 782353
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
Bramwell VH; Morris D; Ernst DS; Hings I; Blackstein M; Venner PM; Ette EI; Harding MW; Waxman A; Demetri GD
Clin Cancer Res; 2002 Feb; 8(2):383-93. PubMed ID: 11839653
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma.
Warrell RP; Kempin SJ
Am J Clin Oncol; 1983 Feb; 6(1):81-4. PubMed ID: 6573124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
